These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 23904864)

  • 21. Cathepsin K Inhibitors for Osteoporosis: Biology, Potential Clinical Utility, and Lessons Learned.
    Drake MT; Clarke BL; Oursler MJ; Khosla S
    Endocr Rev; 2017 Aug; 38(4):325-350. PubMed ID: 28651365
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bone density, turnover, and estimated strength in postmenopausal women treated with odanacatib: a randomized trial.
    Brixen K; Chapurlat R; Cheung AM; Keaveny TM; Fuerst T; Engelke K; Recker R; Dardzinski B; Verbruggen N; Ather S; Rosenberg E; de Papp AE
    J Clin Endocrinol Metab; 2013 Feb; 98(2):571-80. PubMed ID: 23337728
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Odanacatib (MK-0822)].
    Nagase Y; Tanaka S
    Clin Calcium; 2011 Jan; 21(1):59-62. PubMed ID: 21187595
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New insights into treatment of osteoporosis in postmenopausal women.
    Geusens P
    RMD Open; 2015; 1(Suppl 1):e000051. PubMed ID: 26557374
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potent and selective inhibition of human cathepsin K leads to inhibition of bone resorption in vivo in a nonhuman primate.
    Stroup GB; Lark MW; Veber DF; Bhattacharyya A; Blake S; Dare LC; Erhard KF; Hoffman SJ; James IE; Marquis RW; Ru Y; Vasko-Moser JA; Smith BR; Tomaszek T; Gowen M
    J Bone Miner Res; 2001 Oct; 16(10):1739-46. PubMed ID: 11585335
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of the cathepsin K inhibitor odanacatib administered once weekly on bone mineral density in Japanese patients with osteoporosis--a double-blind, randomized, dose-finding study.
    Nakamura T; Shiraki M; Fukunaga M; Tomomitsu T; Santora AC; Tsai R; Fujimoto G; Nakagomi M; Tsubouchi H; Rosenberg E; Uchida S
    Osteoporos Int; 2014 Jan; 25(1):367-76. PubMed ID: 23716037
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of postmenopausal osteoporosis with odanacatib.
    Chapurlat RD
    Expert Opin Pharmacother; 2014 Mar; 15(4):559-64. PubMed ID: 24456412
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Regulation of bone metabolism in osteoporosis : novel drugs for osteoporosis in development].
    Jakob F; Genest F; Baron G; Stumpf U; Rudert M; Seefried L
    Unfallchirurg; 2015 Nov; 118(11):925-32. PubMed ID: 26471379
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Mild Inhibition of Cathepsin K Paradoxically Stimulates the Resorptive Activity of Osteoclasts in Culture.
    Pirapaharan DC; Søe K; Panwar P; Madsen JS; Bergmann ML; Overgaard M; Brömme D; Delaisse JM
    Calcif Tissue Int; 2019 Jan; 104(1):92-101. PubMed ID: 30194476
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Continuous treatment with odanacatib for up to 8 years in postmenopausal women with low bone mineral density: a phase 2 study.
    Rizzoli R; Benhamou CL; Halse J; Miller PD; Reid IR; Rodríguez Portales JA; DaSilva C; Kroon R; Verbruggen N; Leung AT; Gurner D
    Osteoporos Int; 2016 Jun; 27(6):2099-107. PubMed ID: 26879200
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of cathepsin K for treatment of osteoporosis.
    Boonen S; Rosenberg E; Claessens F; Vanderschueren D; Papapoulos S
    Curr Osteoporos Rep; 2012 Mar; 10(1):73-9. PubMed ID: 22228398
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased fracture callus mineralization and strength in cathepsin K knockout mice.
    Gentile MA; Soung do Y; Horrell C; Samadfam R; Drissi H; Duong LT
    Bone; 2014 Sep; 66():72-81. PubMed ID: 24928497
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of SI-591, a new class of cathepsin K inhibitor with peptidomimetic structure, on bone metabolism in vitro and in vivo.
    Fujii T; Ishikawa M; Kubo A; Tanaka Y
    Bone; 2015 Dec; 81():427-434. PubMed ID: 26297834
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A highly potent inhibitor of cathepsin K (relacatib) reduces biomarkers of bone resorption both in vitro and in an acute model of elevated bone turnover in vivo in monkeys.
    Kumar S; Dare L; Vasko-Moser JA; James IE; Blake SM; Rickard DJ; Hwang SM; Tomaszek T; Yamashita DS; Marquis RW; Oh H; Jeong JU; Veber DF; Gowen M; Lark MW; Stroup G
    Bone; 2007 Jan; 40(1):122-31. PubMed ID: 16962401
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of cysteine protease disturbs the topological relationship between bone resorption and formation in vitro.
    Ono S; Tsuji N; Sakamoto T; Oguchi S; Nakamura T; Hoshi K; Hikita A
    J Bone Miner Metab; 2024 Mar; 42(2):166-184. PubMed ID: 38376670
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Future directions for new medical entities in osteoporosis.
    Ferrari S
    Best Pract Res Clin Endocrinol Metab; 2014 Dec; 28(6):859-70. PubMed ID: 25432357
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effects of the cathepsin K inhibitor odanacatib on osteoclastic bone resorption and vesicular trafficking.
    Leung P; Pickarski M; Zhuo Y; Masarachia PJ; Duong LT
    Bone; 2011 Oct; 49(4):623-35. PubMed ID: 21718816
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment needs and current options for postmenopausal osteoporosis.
    Gennari L; Rotatori S; Bianciardi S; Nuti R; Merlotti D
    Expert Opin Pharmacother; 2016 Jun; 17(8):1141-52. PubMed ID: 27055223
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bone modeling and remodeling: potential as therapeutic targets for the treatment of osteoporosis.
    Langdahl B; Ferrari S; Dempster DW
    Ther Adv Musculoskelet Dis; 2016 Dec; 8(6):225-235. PubMed ID: 28255336
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Odanacatib for the treatment of postmenopausal osteoporosis.
    Chapurlat RD
    Expert Opin Pharmacother; 2014 Jan; 15(1):97-102. PubMed ID: 24156249
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.